UK MHRA Approves Skymount Trial For Covid-19 Therapeutics Discovered Using AI
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has given the approval to the Skymount Medical for the purpose of commencing a clinical trial of the company’s oral treatments for the mild and moderate corona virus disease. The human trial is going to be analysing the potential impact of a combination of two drugs […]
Continue Reading